By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Orexigen Therapeutics, Inc. 

48 Wall Street
Suite 1100
New York  New York  10005  U.S.A.
Phone: 212-918-4650 Fax: 212-918-4801


SEARCH JOBS


Industry
Biotechnology






Company News
Orexigen Therapeutics, Inc. (OREX) Reports Corporate And Financial Results For The Second Quarter Ended June 30, 2014 8/7/2014 9:31:40 AM
Orexigen Therapeutics, Inc. (OREX) To Host Second Quarter 2014 Financial Results Conference Call And Webcast 7/31/2014 9:38:41 AM
Orexigen Therapeutics, Inc. (OREX) Receives CHMP Day 180 List Of Outstanding Issues 7/30/2014 9:19:53 AM
Orexigen Therapeutics, Inc. (OREX) To Present At The Wells Fargo Securities 2014 Healthcare Conference 6/13/2014 7:09:41 AM
Orexigen Therapeutics, Inc. (OREX)'s Much Anticipated Weight Loss Drug NB32 Gets New PDUFA Date From The FDA 6/11/2014 5:26:58 AM
Orexigen Therapeutics, Inc. (OREX)'s Contrave: Is This The Weight Loss Drug We've Been Waiting For? 6/10/2014 8:38:21 AM
Orexigen Therapeutics, Inc. (OREX)'s Diet Pill Contrave May Get FDA Approval This Week 6/10/2014 7:14:41 AM
Orexigen Therapeutics, Inc. (OREX) Announces June 11, 2014 PDUFA Action Date For NB32 6/2/2014 9:43:04 AM
Orexigen Therapeutics, Inc. (OREX) To Present At The Bank of America (BAC) Merrill Lynch 2014 Health Care Conference 5/12/2014 6:20:56 AM
Orexigen Therapeutics, Inc. (OREX) Reports Corporate and Financial Results for the First Quarter Ended March 31, 2014 5/9/2014 6:18:33 AM
12345678910...
//-->